8.5 Acute ataxia
Introduction
Ataxia is an uncommon, but important paediatric presentation to the emergency department (ED). Ataxia is a disorder of movement manifest by the loss of coordination, most apparent as a disturbance of gait, with intact muscle strength. It may be associated with a disturbance of balance. Ataxia is most often caused by a loss of function of the cerebellum, which controls the coordination of movement. Disease of the peripheral sensory nerves or the spinal column, particularly affecting proprioception, may also lead to ataxia as a result of abnormal inputs into the cerebellum. Cortical ataxia results from cerebral cortical dysfunction, particularly of the frontal lobe, while vestibular ataxia results from disease of the inner ear. Rarely, psychiatric causes of ‘ataxia’ may also be seen as a manifestation of conversion reaction. The most common diagnosis of acute ataxia in children is a post-infectious ataxia called acute cerebellar ataxia (see below). This is a diagnosis of exclusion, made after consideration of other causes (Table 8.5.1). These include poisoning, metabolic disorders and organic brain lesion.
Differential diagnosis
Acute cerebellar ataxia
Acute cerebellar ataxia is the most common diagnosis in acute ataxia in children, particularly between 2 and 7 years of age. It is a diagnosis of exclusion, after consideration of more sinister causes such as tumours. An autoimmune aetiology is likely, with autoantibodies demonstrated in acute cerebellar ataxia following infections with varicella,1,2 Epstein–Barr virus (EBV),3 mycoplasma and human parvovirus B19.4 The clinical presentation is of a prodromal illness, frequently non-specific, with or without an exanthema, 5–10 days prior to the onset of acute ataxia, though the timing may show considerable variation. If a specific aetiology is present it is most commonly varicella,5 though a number of other viruses have been implicated (Table 8.5.2).6–22 Acute cerebellar ataxia usually presents with sudden onset of severe gait ataxia, though a small number of cases have an insidious onset. Most have dysarthric speech. Mild horizontal nystagmus occurs in 50% of cases. Findings of intention tremor, dysdiadochokinesis, hypotonia and decreased or pendular reflexes are seen in two-thirds of cases, but are less pronounced than the gait disturbance. Truncal ataxia is uncommon. Unlike acute disseminated encephalomyelitis (ADEM) or multiple sclerosis, there are no focal neurological signs.
Investigations are aimed at excluding an alternative diagnosis, if the diagnosis is unclear. The computerised tomography (CT) scan is normal in acute cerebellar ataxia; however, magnetic resonance imaging (MRI) may be abnormal. In one series, inflammatory changes were seen in the cerebellum of one of nine children.23,24 There is a slight elevation of CSF cell count by 4–50 cells per microlitre in 32%, though occasionally (in 8%) the elevation is higher. There may also be slightly elevated protein 410–900 mg L–1.25
Acute cerebellar ataxia usually begins to improve within a few days, but full recovery may take from 10 days to 2 months. Patients who have a slower recovery are still likely to recover fully. In one series, 91% recovered fully from their ataxia, including all those with varicella, EBV or post-vaccination, but 8% had sustained learning problems. Varicella-associated ataxia recovered quicker than non-varicella.24
Poisoning
Accidental poisoning occurs most commonly in 1 to 4-year-old children. A wide variety of compounds are implicated, including alcohols, substances of abuse and essential oils, as well as medications (Table 8.5.3). In addition to ataxia, these children may have nystagmus, altered mental status and vomiting. This is different to acute cerebellar ataxia where consciousness is unimpaired.
Anticonvulsants
Phenytoin toxicity with serum levels of >20–30 mcg mL–1 may produce signs of ataxia, nystagmus on lateral gaze and drowsiness. Onset of symptoms following an acute ingestion is usually within 1–2 hours and may persist for 4–5 days. At >30 mcg mL–1, the ataxia and drowsiness become more marked and the nystagmus vertical.26–28
Carbamazepine toxicity may also lead to ataxia. There are usually associated findings of drowsiness and nystagmus. There may be progression to seizures and coma, particularly if the level is >100 μmol L–1.29
Benzodiazepines
Ataxia may be the sole presenting feature of benzodiazepine ingestion in children. In one series, it was an isolated finding in one-fifth of the cases who demonstrated ataxia. Other findings included lethargy (57%), GCS <15 (35%) and respiratory depression (9%).30
Alcohols
Ethylene glycol is the main component of antifreeze. Early symptoms of ingestion are similar to those of ethanol intoxication. Delayed features include cardiopulmonary distress and nephrotoxicity. Ethylene glycol produces a raised anion gap metabolic acidosis with osmolal gap. Serum levels >20 mg dL–1 are toxic. The ethanol level will be zero. Isopropanol, a component of rubbing alcohol, is used widely as a solvent. Toxicity is evident between 0.5 and 2 hours post-ingestion and may include vomiting, ataxia, nystagmus, and altered mental state. Coma and apnoea may occur in severe poisoning.31
Essential oils
Eucalyptus oil is not an uncommon ingestion by children. In one series of 109 admitted children, 41% were asymptomatic. Those who were symptomatic demonstrated decreased conscious state (28%), vomiting (37%), ataxia (15%) and pulmonary disease (11%). There was a correlation between ingested dose and toxicity. An ingestion of >5 mL 100% oil was associated with a significantly decreased conscious state, whereas <2–3 mL was associated with minor depression of consciousness.32 A second series of 41 presentations, however, only demonstrated effects in 20%, with no correlation with presumed dose. The clinical effects included ataxia (5%), decreased conscious state (10%) and gastrointestinal symptoms (7%).33
Other essential oils that may produce nystagmus include tea tree oil34 and pine oil. In one small series of pine oil cleaner (35% pine oil, 10.9% isopropyl alcohol), symptoms developed within 90 minutes of ingestion. Lethargy was present in all symptomatic children and ataxia in four of five cases of children.35
Cough suppressants
Codeine is contained in a number of cough medicines as well as in analgesics. In one series of 430 children, ataxia was reported in 9% receiving codeine. Associated symptoms are somnolence 67%, rash 39%, miosis 30%, vomiting 27%, itching 10%, angio-oedema 9%.36 Dextromethorphan is a common component of cough and cold medications, which acts through opiate receptors in the medulla. It may cause opisthotonus, ataxia and bidirectional nystagmus. Fatality is highly unlikely, even with one hundred-fold the therapeutic dose.37,38
Substances of abuse
Phencyclidine (PCP) and lysergic acid diethylamide (LSD) are rare causes of ataxia in children. 1,4-butanediol, which is metabolised to gamma-hydroxybutyrate (GHB) upon ingestion, was responsible for ataxia, vomiting and seizures in several children following the ingestion of Aqua Dots, from toy craft kits.39
Tumours
An occult neuroblastoma may present with a triad of acute ataxia, opsoclonus (jerky, random, chaotic eye movements) and myoclonus (severe myoclonic jerks of the head, trunk or limbs). The most common site for the tumour is in the abdomen.40 The triad may also be seen with viral infections, including meningitis, particularly mumps, hence a lumbar puncture should be considered. Neuroblastoma may present with isolated ataxia and should be considered in cases of persistent or recurrent ataxia.41
Infections
Meningitis and encephalitis may both have ataxia as a presenting feature.42,43 Other features to suggest an infective cause, such as headache, vomiting, fever and neck stiffness in the older child, will usually be evident.
Vascular conditions
Vertebrobasilar stroke is a very uncommon cause of ataxia in children. Ataxia will not be an isolated finding. Other findings include ipsilateral cranial nerve palsies, contralateral weakness, vertigo and diplopia. Systemic lupus erythematosus vasculitis may rarely present with ataxia.44
Other neurological conditions
In ataxia there is preservation of muscle strength. A number of neurological conditions may present with an unsteady gait (pseudo-ataxia) because of weakness. These include Guillain–Barré syndrome in which areflexia and ophthalmoplegia (in Miller–Fisher variant) distinguish it from acute cerebellar ataxia. Tick paralysis should also be considered in cases where the patient has been in an appropriate area. Multiple sclerosis/transverse myelitis is usually not seen until adolescent years. It may present with ataxia, optic or retinal neuritis, regional paraesthesias or weakness.45 ADEM, a post-infectious encephalomyelitis, where host myelin components become immunogenic, may have ataxia as one neurological sign. The diagnosis is made by abnormal CT and MRI findings.
Metabolic disorders
A large number of metabolic disorders may have ataxia as a feature and should be kept in mind. Hypoglycaemia and hyponatraemia may present with ataxias but other signs will also be present. The inherited metabolic diseases will likely demonstrate episodes of ataxia, together with the other features of the conditions, which will point towards the diagnosis. There may be a progression to chronic ataxias. Other inborn errors are listed in Table 8.5.4.
Chronic ataxia
Chronic ataxia usually has an insidious onset but it may present as a progression of acute ataxia, or as recurrent episodes. Causes include fixed deficits as in ataxic cerebral palsy, which makes up 10% of cerebral palsy and progressive diseases such as the hereditary ataxia, inborn errors of metabolism and tumours. Some causes are amenable to treatment. Table 8.5.4 lists some of the causes.
1 Adams C., Diadori P., Schoenroth L., Fritzler M. Autoantibodies in childhood post-varicella acute cerebellar ataxia. Can J Neurol Sci. 2000;27:316-320.
2 Van der Mass A.A.T., Vermeer-de Bondt P.E., de Melker H., Kemmeren J.M. Acute cerebellar ataxia in the Netherlands: A study on the association with vaccinations and varicella zoster infection. Vaccine. 2009;27(13):1970-1973.
3 Uchibori A., Sakuta M., Kusunoki S., Chiba A. Autoantibodies in postinfectious cerebellar ataxia. Neurology. 2005;65(7):1114-1116.
4 Shimizu Y., Ueno T., Komatsu H., et al. Acute cerebellar ataxia with human parvovirus B19 infection. Arch Dis Child. 1999;80(1):72-73.
5 Nussinovitch M., Prais D., Volovitz B., et al. Post-infectious cerebellar ataxia in children. Clin Pediatr. 2003;42(7):581-584.
6 Dreyfus P.M., Senter T.P. Acute cerebellar ataxia of childhood. An unusual case of varicella. W J Med. 1974;120(2):161-163.
7 Feldman W., Larke R.P. Acute cerebellar ataxia associated with the isolation of Coxsackie virus type A9. Can Med Assoc J. 1972;106(10):1104.
8 Erzurum S., Kalavsky S.M., Watanakunakorn C. Acute cerebellar ataxia and hearing loss as initial symptoms of infectious mononucleosis. Arch Neurol. 1983;40(12):760-762.
9 Steele J.C., Gladstone R.M., Thanasophon S., Fleming P. Acute cerebellar ataxia and concomitant infection with Mycoplasma pneumoniae. J Pediatr. 1972;80(3):467-469.
10 Cohen H.A., Ashkenazi A., Nussinovitch M., et al. Mumps-associated acute cerebellar ataxia. Am J Dis Child. 1992;146(8):930-931.
11 Gupta P.C., Gathwala G., Aneja S., Arora S.K. Acute cerebellar ataxia: An unusual presentation of poliomyelitis. Indian Pediatr. 1990;27(6):622-623.
12 Curnen E.C., Chamberlin H.R. Acute cerebellar ataxia associated with poliovirus infection. Yale J Biol Med. 1962;34:219.
13 Thapa B.R., Sahni A. Acute reversible cerebellar ataxia in typhoid fever. Indian Pediatr. 1993;30(3):427.
14 Marzetti G., Midulla M. Acute cerebellar ataxia associated with echo type 6 infection in two children. Acta Paediatr Scand. 1967;56:547.
15 Batton F.E. Ataxia in childhood. Brain. 1905;28:487-505.
16 Shimizu Y., Ueno T., Komatsu H., et al. Acute cerebellar ataxia with human parvovirus B19 infection. Arch Dis Child. 1999;80(1):72-73.
17 Dano G. Acute cerebellar ataxia associated with herpes simplex virus infection. Acta Paediatr Scand. 1968;57:151.
18 McMinn P., Stratov I., Nagarajan L., Davis S. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot and mouth disease in Western Australia. Clin Infect Dis. 2001;32(2):236-242.
19 Senanayake N., de Silva H.J. Delayed cerebellar ataxia complicating falciparum malaria: A clinical study of 74 patients. J Neurol. 1999;241(7):456-459.
20 Sunaga Y., Hikima A., Ostuka T., Morikawa A. Acute cerebellar ataxia with abnormal MRI lesions after varicella vaccination. Pediatr Neurol. 1995;13(4):340-342.
21 Deisenhammer F., Pohl P., Bosch S., Schmidauer C. Acute cerebellar ataxia after immunization with recombinant hepatitis B vaccine. Acta Neurol Scand. 1994;89(6):462-463.
22 Hata A., Fujita M., Morishima T., et al. Acute cerebellar ataxia associated with primary human herpesvirus-6 infection: a report of two cases. J Paediatr Child Health. 2008;44(10):607-609.
23 Maggi G., Varone A., Aliberti F. Acute cerebellar ataxia in children. Childs Nerv Syst. 1997;13(10):542-545.
24 Connolly A.M., Dodson W.E., Prensky A.L., Rust R.S. Course and outcome of acute cerebellar ataxia. Ann Neurol. 1994;35:673-679.
25 Siemes H., Siegert M., Jaroffke B., Hanefield F. The CSF protein pattern in acute cerebellar ataxia of childhood and intracranial midline tumours. Eur J Pediatr. 1982;137(1):49-57.
26 Murphy J.M., Motiwala R., Devinsky O. Phenytoin intoxication. S Med J. 1991;84:1199-1204.
27 Wilson J.T., Huff J.G., Kilroy A.W. Prolonged toxicity following acute phenytoin overdose in a child. J Pediatr. 1979:95135-95138.
28 Booker H.E., Darcey B. Serum concentrations of free diphenylhydantoin and their relationship to intoxication. Epilepsia. 1973;14:177.
29 Tibballs J. Acute toxic reaction to carbamazepine: Clinical effects and serum concentrations. J Pediatr. 1992;121(2):295-299.
30 Wiley C.C., Wiley J.F. Pediatric benzodiazepine ingestion resulting in hospitalization. J Toxicol. 1998;36(3):227-231.
31 Stremski E., Hennes H. Accidental isopropanol ingestion in children. Pediatr Emerg Care. 2000;16(4):238-240.
32 Tibballs J. Clinical effects and management of eucalyptus oil ingestion in infants and young children. Med J Aust. 1995;163(4):177-180.
33 Webb N.J.A., Pitt W.R. Eucalyptus oil poisoning in childhood: 41 cases in South-East Queensland. J Paediatr Child Health. 1993;29:368-371.
34 Del Beccaro M.A. Melaleuca oil poisoning in a 17-month-old. Vet Hum Toxicol. 1995;37(6):557-558.
35 Brook M.P., McCarron M.M., Mueller J.A. Pine oil ingestion. Ann Emerg Med. 1989;18(4):391-395.
36 Von Muhlendahl K.E., Kreinke E.G., Scherrf-Rahne B., Baukloh G. Codeine intoxication in childhood. Lancet. 1976;16:303-305.
37 Warden C.R., Diekema D.S., Robertson W.O. Dystonic reaction associated with dextromethorphan ingestion in a toddler. Pediatr Emerg Care. 1997;13(3):214-215.
38 Bem J.L., Peck R. Dextromethorphan: An overview of safety issues. Drug Saf. 1992;7(3):190-199.
39 Suchard J., Nizkorodov S., Wilkinson S. 1,4-Butanediol content of aqua dots children’s craft toy beads. J Med Toxicol. 2009;5(3):120-124.
40 Telander R.L., Smithson A., Groover V. Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma. J Pediatr Surg. 1989;24(1):11-14.
41 Blokker R.S., Smit L.M.E., van den Bos C., et al. Ned Tijdschr Geneeskd. 2006;150(14):799-803.
42 Kaplan S., Goddard J., Van Kleeck M., et al. Ataxia and deafness in children due to bacterial meningitis. Paediatrics. 1981;68:8-13.
43 Iff T., Donati F., Vassella F., et al. Acute encephalitis in Swiss children: Aetiology and outcome. Eur J Paediatr Neurol. 1998;2:233-237.
44 Yaginuma M., Suenaga M., Shiono Y., Sakamoto M. Acute cerebellar ataxia of a patient with SLE. Clin Neurol Neurosurg. 2000;102(1):37-39.
45 Rust R.S. Multiple sclerosis, acute disseminated encephalomyelitis, and related conditions. Semin Pediatr Neurol. 2000;7(2):66-90.